YANA ROMANOV: Open Payments
NPI 1770707192 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 44 payments from 16 companies in 2025. Trend: 2023 $994 · 2024 $661 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $478 |
| Amgen Inc. | 5 | $201 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Lilly USA, LLC | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Exact Sciences Corporation | 3 | $59 |
| ABIOMED | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| ABBVIE INC. | 1 | $20 |
Products named: Ozempic, REPATHA, VOQUEZNA, MOUNJARO, JARDIANCE, Cologuard Collection Kit, Wegovy, REXULTI.
Industry payments across TX — which companies pay providers there.
